Synthesis and preclinical evaluation of [C-11]D617, a metabolite of (R)-[C-11]verapamil

J. Verbeek; S. Syvanen; R.C. Schuit; P.A.J. Eriksson; E.C.M. de Lange; A.D. Windhorst; G. Luurtsema; A.A. Lammertsma

doi:https://doi.org/10.1016/j.nucmedbio.2011.10.017

Synthesis and preclinical evaluation of [C-11]D617, a metabolite of (R)-[C-11]verapamil

J. Verbeek, S. Syvanen, R.C. Schuit, P.A.J. Eriksson, E.C.M. de Lange, A.D. Windhorst, G. Luurtsema, A.A. Lammertsma

Radiology and Nuclear Medicine (VUmc)

Research output: Contribution to journal › Article › Academic › peer-review

17 Citations (Scopus)

Original language	English
Pages (from-to)	530-539
Journal	Nuclear medicine and biology
Volume	39
Issue number	4
DOIs	https://doi.org/10.1016/j.nucmedbio.2011.10.017
Publication status	Published - 2012

Access to Document

https://doi.org/10.1016/j.nucmedbio.2011.10.017

Cite this

@article{8cbdb265a248402db1a0a4929158d5c8,

title = "Synthesis and preclinical evaluation of [C-11]D617, a metabolite of (R)-[C-11]verapamil",

author = "J. Verbeek and S. Syvanen and R.C. Schuit and P.A.J. Eriksson and {de Lange}, E.C.M. and A.D. Windhorst and G. Luurtsema and A.A. Lammertsma",

year = "2012",

doi = "https://doi.org/10.1016/j.nucmedbio.2011.10.017",

language = "English",

volume = "39",

pages = "530--539",

journal = "Nuclear medicine and biology",

issn = "0969-8051",

publisher = "Elsevier Inc.",

number = "4",

}

TY - JOUR

T1 - Synthesis and preclinical evaluation of [C-11]D617, a metabolite of (R)-[C-11]verapamil

AU - Verbeek, J.

AU - Syvanen, S.

AU - Schuit, R.C.

AU - Eriksson, P.A.J.

AU - de Lange, E.C.M.

AU - Windhorst, A.D.

AU - Luurtsema, G.

AU - Lammertsma, A.A.

PY - 2012

Y1 - 2012

U2 - https://doi.org/10.1016/j.nucmedbio.2011.10.017

DO - https://doi.org/10.1016/j.nucmedbio.2011.10.017

M3 - Article

C2 - 22226023

SN - 0969-8051

VL - 39

SP - 530

EP - 539

JO - Nuclear medicine and biology

JF - Nuclear medicine and biology

IS - 4

ER -